What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2023-03-31 compared with 2022-03-31 · 197 added, 161 removed, 6 unchanged (98% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Information .

As of August 3, 2021, our common stock, par value $.001 per share (the “Common Stock”), is currently

quoted on the Nasdaq Capital Markets under the symbol “ABVC”.

following table sets forth the range of high and low bid quotations for our common stock.

The quotations represent inter-dealer

prices without retail markup, markdown or commission, and may not necessarily represent actual transactions.

As of March 30, 2022, we had approximately 706 shareholders of record of our common stock.

Holders of our common stock are entitled to receive such dividends as may be declared by our board of directors.

No dividends on

our common stock have ever been paid, and we do not anticipate that dividends will be paid on our common stock in the foreseeable future.

authorized for issuance under equity incentive plans.

Compensation Plan Information

The following

table discloses information as of December 31, 2021, with respect to compensation plans (including individual compensation arrangements)

under which our equity securities are authorized for issuance, aggregated as follows:

Plan category

available for

compensation plans approved by security holders

compensation plans not approved by security holders

Item 11, Executive Compensation for additional details about our option plan.

Sales of Unregistered Securities .

the period covered by this report, the Company has not issued unregistered securities to any person, except as described below.

of these transactions involved any underwriters, underwriting discounts or commissions, except as specified below, or any public offering,

and, unless otherwise indicated below, the Registrant believes that each transaction was exempt from the registration requirements of

the Securities Act by virtue of Section 4(a)(2) thereof and/or Rule 506 of Regulation D promulgated thereunder,

and/or Regulation S promulgated thereunder regarding offshore offers and sales.

All recipients had adequate access, though

their relationships with the Registrant, to information about the Registrant.

January 21, 2020, the Company entered into three note agreements with existing note investors who executed the agreements in 2018.

three investors are Guoliang Yu and Yingfei Wei Family Trust, Keypoint Technology Ltd., and Yoshinobu Odaira.

The new agreements bear

the same term as other notes investors who executed the contract in 2019.

On April 5, 2020, the Company entered into exchange agreements

with such note holders.

Pursuant to the exchange agreements, the Holders agreed to deliver the Notes to the Company for cancellation,

of which the aggregate principal amount plus accrued interest expenses are $931,584, and the Company issued to the Holders an aggregate

of 506,297 shares of the Company’s common stock, and warrants to purchase 506,297 shares of the Company’s common stock.

April 5, 2020 and April 20, 2020, the Company entered into certain exchange agreements separately with certain U.S.

who are holders of certain convertible promissory notes issued by the Company in the aggregate amount of $1,446,780.

MARKET FOR REGISTRANT’S COMMON

EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information .

3, 2021, our common stock, par value $.001 per share (the “Common Stock”), is currently quoted on the Nasdaq Capital Markets

under the symbol “ABVC”.

As of March 31, 2023, we had approximately 666 shareholders

of record of our common stock.

Holders of our common

stock are entitled to receive such dividends as may be declared by our board of directors.

No dividends on our common stock have ever

been paid, and we do not anticipate that dividends will be paid on our common stock in the foreseeable future.

Recent Sales of Unregistered Securities .

During the period covered by this report, the

Company has not issued unregistered securities to any person, except as described below.

None of these transactions involved any underwriters,

underwriting discounts or commissions, except as specified below, or any public offering, and, unless otherwise indicated below, the

Registrant believes that each transaction was exempt from the registration requirements of the Securities Act by virtue of

Section 4(a)(2) thereof and/or Rule 506 of Regulation D promulgated thereunder, and/or Regulation S promulgated

thereunder regarding offshore offers and sales.

All recipients had adequate access, though their relationships with the Registrant, to

information about the Registrant.

During the year ended December 31, 2019, the Company

entered into service agreements with Euro-Asia Investment & Finance Corp Ltd.

(a related party), Ever Adventure inv.

(Formosa) Consultant

Co., Ltd., New Eastern Asia (a related party), and Kimho Consultants Co., Ltd.

(a related party) for the maintenance of the listing in

stock exchange market, investor relations, and business development.

Pursuant to the agreements, the Company issued 644,972 shares

of the Company’s common stock for the consulting service from July 2019 to July 2024 for the service fee of $4,514,800 in aggregate,

and recorded as stock subscription receivable.

As of December 31, 2022 and 2021, stock subscription receivable was $1,354,440 and $2,257,400,

respectively.

On January 21, 2020, the Company entered into

three note agreements with existing note investors who executed the agreements in 2018.

These three investors are Guoliang Yu and Yingfei

Wei Family Trust, Keypoint Technology Ltd., and Yoshinobu Odaira.

The new agreements bear the same term as other notes investors who

executed the contract in 2019.

On April 5, 2020, the Company entered into exchange agreements with such note holders.

Pursuant to the

exchange agreements, the Company agreed to issue to the Holders an aggregate of 795,735 shares of the Company’s common stock, and

warrants to purchase 795,735 shares of common stock.

Each warrant is exercisable upon issuance and expires three years from the date

The initial exercise price of the warrant is $5.00, subject to stock, splits, stock dividend and other similar events.

addition, when the closing price of the common stock equals or exceeds $9.00 per share for twenty Trading Days (as defined in the exchange

agreements) during any thirty-day period, the Company shall have the right to require the holders to exercise all or any portion of the

note holders’ warrants for a cash exercise.

On September 30, 2020, the Company has issued such note holders’ shares warrants

to the holders and closed the transactions contemplated by the Exchange Agreements.

May 2020, the Company received capital contributions of approximately $1,602,040 in cash from 40 investors through private placements

of the sale of certain number of Common Stocks for the purchase price of $2.25 per share of Common Stock and a free warrant attaches

with each Common stock that was purchased.

The exercise price of the warrant is at $6.00 per common stock with a mandatory redemption

at $9.00 per common stock pursuant to the terms and conditions of the warrants.

July 8, 2020, the Company entered an agreement with View Trade Securities Inc.

(“ ViewTrade ”) to engage ViewTrade as

the placement agent and the Company’s advisor with respect to its ongoing capital events.

Pursuant to the agreement, the Company

agreed to pay View Trade (“ ViewTrade Securities ”) 60,000 restricted common shares of the Company and 60,000 warrants

to purchase common shares of the Company at an exercise price of $6 per share for a period of 5 years with cashless exercise provision.

As of December 31, 2021, the Company has issued 60,000 shares of common stock to ViewTrade for the advisory services with an estimated

value of $135,000.

The warrants were never issued and the parties mutually agreed to terminate the agreement on November 19, 2020.

a termination fee, the Company agreed to issue ViewTrade 50,000 restricted common shares of the Company.

on November 19, 2020, the Company and ViewTrade agreed to a new Advisory agreement under which ViewTrade was engaged to provide advisory

services only.

In addition to a retainer fee, the Company agreed to issue 200,000 warrants, with an exercise price of $2.25, an industry

standard cashless exercise provision, and a term of 5 years from November 19, 2020.

September 30, 2020, the Company also issued to Ever Adventure inv.

exchange agreements, the Holders agreed to deliver the Notes to the Company for cancellation, of which the aggregate principal amount

plus accrued interest expenses are $931,584, and the Company issued to the Holders an aggregate of 506,297 shares of the Company’s

common stock, and warrants to purchase 506,297 shares of the Company’s common stock.

On April 5, 2020 and April 20, 2020, the Company

entered into certain exchange agreements separately with certain U.S.

holders who are holders of certain convertible promissory

notes issued by the Company in the aggregate amount of $1,446,780.

Pursuant to the exchange agreements, the Company agreed to issue to

the Holders an aggregate of 795,735 shares of the Company’s common stock, and warrants to purchase 795,735 shares of common stock.

Each warrant is exercisable upon issuance and expires three years from the date of issuance.

The initial exercise price of the warrant

is $5.00, subject to stock, splits, stock dividend and other similar events.

In addition, when the closing price of the common stock

equals or exceeds $9.00 per share for twenty Trading Days (as defined in the exchange agreements) during any thirty-day period, the Company

shall have the right to require the holders to exercise all or any portion of the note holders’ warrants for a cash exercise.

September 30, 2020, the Company has issued such note holders’ shares warrants to the holders and closed the transactions contemplated

by the Exchange Agreements.

In May 2020, the Company received capital contributions

of approximately $1,602,040 in cash from 40 investors through private placements of the sale of certain number of Common Stocks for the

purchase price of $2.25 per share of Common Stock and a free warrant attaches with each Common stock that was purchased.

price of the warrant is at $6.00 per common stock with a mandatory redemption at $9.00 per common stock pursuant to the terms and conditions

of the warrants.

On July 8, 2020, the Company entered an agreement

with View Trade Securities Inc.

(“ ViewTrade ”) to engage ViewTrade as the placement agent and the Company’s advisor

with respect to its ongoing capital events.

Pursuant to the agreement, the Company agreed to pay View Trade (“ ViewTrade Securities ”)

60,000 restricted common shares of the Company and 60,000 warrants to purchase common shares of the Company at an exercise price of $6

per share for a period of 5 years with cashless exercise provision.

As of December 31, 2021, the Company has issued 60,000 shares of

common stock to ViewTrade for the advisory services with an estimated value of $135,000.

The warrants were never issued and the parties

mutually agreed to terminate the agreement on November 19, 2020.

As a termination fee, the Company agreed to issue ViewTrade 50,000 restricted

common shares of the Company.

Also on November 19, 2020, the Company and ViewTrade

agreed to a new Advisory agreement under which ViewTrade was engaged to provide advisory services only.

In addition to a retainer fee,

the Company agreed to issue 200,000 warrants, with an exercise price of $2.25, an industry standard cashless exercise provision, and

a term of 5 years from November 19, 2020.

On September 30, 2020, the Company also issued

to Ever Adventure inv.

(Formosa) Consultant Co., Ltd.

(or its designee), Jinwei International

(or its designee), and Thalia Media Ltd.

(or its designee) (the “ Consultants ”) 120,000 shares, 180,000 shares

and 120,000 shares of common stock (collectively, “ Consultants’ Shares ”), respectively, as their compensation

as the Company’s investor relations and business development advisors.

Each Consultant has entered into certain consulting agreement

with the Company.

(or its designee), Jinwei International Co., Ltd.

(or its designee), and Thalia

(or its designee) (the “ Consultants ”) 120,000 shares, 180,000 shares and 120,000 shares of common stock

(collectively, “ Consultants’ Shares ”), respectively, as their compensation as the Company’s investor relations

and business development advisors.

Each Consultant has entered into certain consulting agreement with the Company.

September 30, 2020, the Company issued an aggregate of 795,735 shares of Common Stock to five previous note holders, who had converted

their outstanding principals and accrued and unpaid interests during the nine months ended September 30, 2020.

November 8, 2020, the Company entered into an exchange agreement with a holder of convertible promissory notes issued by the Company

in the aggregate amount of $270,272.

Pursuant to the exchange agreements, the Company agreed to issue to the Holder an aggregate of 120,121

shares of the Company’s common stock, and warrants to purchase 120,121 shares of common stock.

On December 31, 2021, the Company

issued an aggregated of 120,121 shares of Common Stock to the note holder.

November 11, 2020, the Company conducted a closing with regard to certain securities purchase agreements (the “ SPAs ”)

dated October 23, 2020, separately with two non-U.S.

their outstanding principals and accrued and unpaid interests during 2020.

the year ended December 31, 2022, no conversion was made to the note holders.

On November 8, 2020, the Company entered into

an exchange agreement with a holder of convertible promissory notes issued by the Company in the aggregate amount of $270,272.

to the exchange agreements, the Company agreed to issue to the Holder an aggregate of 120,121 shares of the Company’s common stock,

and warrants to purchase 120,121 shares of common stock.

On December 31, 2021, the Company issued an aggregated of 120,121 shares of

Common Stock to the note holder.

On November 11, 2020, the Company conducted a

closing with regard to certain securities purchase agreements (the “ SPAs ”) dated October 23, 2020, separately with

investors (the “ Investors ”).

Each of the Investors agreed to

purchase and the Company agreed to sell to each of the Investors 1,111,112 shares of the Company’s common stock, and warrants to

purchase 1,111,112 shares of common stock, for a purchase price of $2,500,000.

The warrants are exercisable upon issuance and expires

three years from the date of issuance.

The initial exercise price of the warrants is $6.00, subject to stock, splits, stock dividend

and other similar events.

In addition, when the closing price of the common stock equals or exceeds $9.00 per share for twenty Trading

Days (as defined in the exchange agreements) during any thirty-day period, the Company shall have the right to require the investors

to exercise all or any portion of the warrants for a cash exercise.

Each of the Investors agreed to purchase and the Company agreed to sell

to each of the Investors 1,111,112 shares of the Company’s common stock, and warrants to purchase 1,111,112 shares of common stock,

for a purchase price of $2,500,000.

The warrants are exercisable upon issuance and expires three years from the date of issuance.

initial exercise price of the warrants is $6.00, subject to stock, splits, stock dividend and other similar events.

In addition, when

the closing price of the common stock equals or exceeds $9.00 per share for twenty Trading Days (as defined in the exchange agreements)

during any thirty-day period, the Company shall have the right to require the investors to exercise all or any portion of the warrants

for a cash exercise.

The aggregate net proceeds of the Offering were $5,000,000.

and the investors further agreed to amend the terms of the SPA to permit the closing of the offering to occur on a rolling basis.

July 2021, 1,111,112 shares of the Company’s common stock and warrants were issued pursuant to the conversion of a $2,500,000

convertible promissory note.

the year ended December 31, 2020, the Company entered into a consulting agreement with a service provider for consulting and advisory

services, pursuant to which the Company agreed to pay the service fee by issuing 50,000 shares of unrestricted common shares,

valued at the closing price of $2.9 per share on the grant date.

The Company and the investors further agreed to amend

the terms of the SPA to permit the closing of the offering to occur on a rolling basis.

In July 2021, 1,111,112 shares of the

Company’s common stock and warrants were issued pursuant to the conversion of a $2,500,000 convertible promissory note.

During the year ended December 31, 2020,

the Company entered into a consulting agreement with a service provider for consulting and advisory services, pursuant to which the Company

agreed to pay the service fee by issuing 50,000 shares of unrestricted common shares, valued at the closing price of $2.9 per

share on the grant date.

These shares were issued in 2020.

the year ended December 31, 2020, the Company received aggregated capital contributions of $7,615,331 in cash from 45 investors

through private placements of the sale of the Company’s common stock for the purchase price of $2.25 per share and a

free warrant attached with each common stock purchased.

In December 2020, 3,384,615 shares of the Company’s common stock

have been issued.

the year ended December 31, 2021, the Company entered into consulting agreements with four service providers for consulting and advisory

services, pursuant to which the Company agreed to pay the aggregate service fee by issuing a total of 521,887 shares of unrestricted

common shares, valued at the closing price from $2 to $3.68 per share on the grant date.

As of December 31, 2021, these shares have been

the year ended December 31, 2020, the Company issued an aggregate of 915,856 shares of common stock to six previous note holders, who

had converted their outstanding principals and accrued and unpaid interests.

August 5, 2021, the Company closed its public offering (the “Public Offering”) of 1,100,000 units (the “Units”),

with each Unit consisting of one share of the Company’s common stock, one Series A warrant (the “Series A Warrants”)

to purchase one share of common stock at an exercise price equal to $6.30 per share, exercisable until the fifth anniversary of the issuance

date, and one Series B warrant (the “Series B Warrants,” and together with the Series A Warrants, the “Public Warrants”)

to purchase one share of common stock at an exercise price equal to $10.00 per share, exercisable until the fifth anniversary of the

issuance date;

the exercise price of the Public Warrants are subject to certain adjustment and cashless exercise provisions as described

The Company completed the Public Offering pursuant to its registration statement on Form S-1 (File No.

333-255112), originally

filed with the Securities and Exchange Commission (the “SEC”) on April 8, 2021 (as amended, the “Original Registration

Statement”), that the SEC declared effective on August 2, 2021 and the registration statement on Form S-1 (File No.

that was filed and automatically effective on August 4, 2021 (the “S-1MEF,” together with the Original Registration Statement,

the “Registration Statement”).

The Units were priced at $6.25 per Unit, before underwriting discounts and offering expenses,

resulting in gross proceeds of $6,875,000.

The Public Offering was conducted on a firm commitment basis.

In August 2021, 2,354,145 shares

of the Company’s common stock were issued for gross proceeds of $6,875,000, before placement agent fees and legal fees of $850,429.

the year ended December 31, 2019, the Company entered into service agreements with Euro-Asia Investment & Finance Corp Ltd.

party), Ever Adventure inv.

(Formosa) Consultant Co., Ltd., New Eastern Asia (a related party), and Kimho Consultants Co., Ltd.

party) for the maintenance of the listing in the U.S.

stock exchange market, investor relations, and business development.

the agreements, the Company issued 644,972 shares of the Company’s common stock for the consulting service from July 2019 to July

2024 for the service fee of $4,514,800 in aggregate, and recorded as stock subscription receivable.

As of December 31, 2021 and 2020,

stock subscription receivable was $2,257,400 and $3,160,360, respectively.

Company paid the following fees to a FINRA member firm in connection with the private financing transaction that closed on November

(i) a cash success fee of $175,000 and (ii) warrants to purchase a number of shares of Common Stock equal to 7% of the number

of shares of Common Stock sold in this offering, at an exercise price per share equal to $6.00 subject to adjustment (the “ Comp

The Comp Warrants are exercisable on a cashless basis, at the holder’s discretion.

June 29, 2021, we issued 6,000 shares of Common Stock to WallachBeth as compensation for consulting services.

November 2021, the Company issued an aggregate of 316,934 shares of Common Stock to Consultants.

Company also issued an aggregate of 1,306,007 shares of Common Stock to Consultants, who provided consulting services in January 2022;

it issued an additional 75,000 shares to another consultant in March 2022, based on the 6-month consulting and advisory services agreement,

with a monthly payment of USD $15,000.

November 2021, the Company issued 55,000 underwriter warrants to WallachBeth, pursuant to the Company’s engagement of WallachBeth

as the Company’s exclusive placement agent and advisor in connection with the offering for the listing on The Nasdaq Capital Market.

November 2021, the Company received $4,244,452 in gross proceeds from the exercise of warrants issued in the Company’s August

3, 2021 public offering of securities.

Investors exercised a total of 673,405 Series A warrants at a price of $6.30 per

share and 200 Series B warrants at a price of $10 per share.

Pursuant to these exercises, the Company issued an aggregate

of 673,605 shares of Common Stock.

March 2022, the Company issued 75,000 shares to BarLew Holdings, LLC, a consultant (“Barlew”).

On January 1, 2022, the Company

engaged Barlew for consulting and advisory services for six months, with a monthly payment of USD15,000, as well as additional compensation

of 75,000 shares of restricted common stock.

March 2022, the Company issued 242,247 warrants to a FINRA member firm.

During the year ended December 31, 2020, the

Company received aggregated capital contributions of $7,615,331 in cash from 45 investors through private placements of

the sale of the Company’s common stock for the purchase price of $2.25 per share and a free warrant attached with each

common stock purchased.

In December 2020, 3,384,615 shares of the Company’s common stock have been issued.

During the year ended December 31, 2021, the

Company entered into consulting agreements with four service providers for consulting and advisory services, pursuant to which the Company

agreed to pay the aggregate service fee by issuing a total of 521,887 shares of unrestricted common shares, valued at the closing price

from $2 to $3.68 per share on the grant date.

As of December 31, 2021, these shares have been issued.

During the year ended December 31, 2020, the

Company issued an aggregate of 915,856 shares of common stock to six previous note holders, who had converted their outstanding principals

and accrued and unpaid interests.

On August 5, 2021, the Company closed its

public offering (the “Public Offering”) of 1,100,000 units (the “Units”), with each Unit consisting of one share

of the Company’s common stock, one Series A warrant (the “Series A Warrants”) to purchase one share of common stock

at an exercise price equal to $6.30 per share, exercisable until the fifth anniversary of the issuance date, and one Series B warrant

(the “Series B Warrants,” and together with the Series A Warrants, the “Public Warrants”) to purchase one share

of common stock at an exercise price equal to $10.00 per share, exercisable until the fifth anniversary of the issuance date;

price of the Public Warrants are subject to certain adjustment and cashless exercise provisions as described therein.

The Company completed

the Public Offering pursuant to its registration statement on Form S-1 (File No.

333-255112), originally filed with the Securities and

Exchange Commission (the “SEC”) on April 8, 2021 (as amended, the “Original Registration Statement”), that the

SEC declared effective on August 2, 2021 and the registration statement on Form S-1 (File No.

333-258404) that was filed and automatically

effective on August 4, 2021 (the “S-1MEF,” together with the Original Registration Statement, the “Registration Statement”).

The Units were priced at $6.25 per Unit, before underwriting discounts and offering expenses, resulting in gross proceeds of $6,875,000.

Public Offering was conducted on a firm commitment basis.

In August 2021, 2,354,145 shares of the Company’s common stock

were issued for gross proceeds of $6,875,000, before placement agent fees and legal fees of $850,429.

The Company paid the following fees to a FINRA

member firm in connection with the private financing transaction that closed on November 11, 2020:

(i) a cash success fee of $175,000

and (ii) warrants to purchase a number of shares of Common Stock equal to 7% of the number of shares of Common Stock sold in this offering,

at an exercise price per share equal to $6.00 subject to adjustment (the “ Comp Warrants ”).

The Comp Warrants are exercisable

on a cashless basis, at the holder’s discretion.

On June 29, 2021, we issued 6,000 shares of Common

Stock to WallachBeth as compensation for consulting services.

In November 2021, the Company issued an aggregate

of 316,934 shares of Common Stock to Consultants.

The Company also issued an aggregate of 1,306,007

shares of Common Stock to Consultants, who provided consulting services in January 2022;

it issued an additional 75,000 shares to another

consultant in March 2022, based on the 6-month consulting and advisory services agreement, with a monthly payment of USD $15,000.

In November 2021, the Company issued 55,000 underwriter

warrants to WallachBeth, pursuant to the Company’s engagement of WallachBeth as the Company’s exclusive placement agent and

advisor in connection with the offering for the listing on The Nasdaq Capital Market.

In November 2021, the Company received $4,244,452 in

gross proceeds from the exercise of warrants issued in the Company’s August 3, 2021 public offering of securities.

Investors exercised

a total of 673,405 Series A warrants at a price of $6.30 per share and 200 Series B warrants at a price of $10 per

Pursuant to these exercises, the Company issued an aggregate of 673,605 shares of Common Stock.

In January 2022, the Company agreed to pay the

deferred service fees related to the Offering amounting to $4,296,763 by issuing 1,306,007 shares of unrestricted common shares, valued

at $3.29 per share on the grant date.

In March 2022, the Company issued 75,000 shares

to BarLew Holdings, LLC, a consultant (“Barlew”).

On January 1, 2022, the Company engaged Barlew for consulting and advisory

services for six months, with a monthly payment of USD15,000, as well as additional compensation of 75,000 shares of restricted common

In March 2022, the Company issued 242,247 warrants

to a FINRA member firm.

On May 11, 2022, the

Company and certain investors entered into certain securities purchase agreement relating to the offer and sale of 2,000,000 shares

of common stock, par value $0.001 per share in a registered direct offering.

On July 10, 2022, the

Board approved the issuance of 75,000 shares of common stock to Barlew Holdings, LLC pursuant to the consulting agreement by and between

Barlew Holdings, LLC and the Company dated July 1, 2022, and 250,000 shares of common stock to Inverlew Advisors, LLC, in accordance with

the consulting agreement by and between Inverlew Advisors, LLC and the Company dated July 1, 2022.

On December 1, 2022, the Company issued 125,000

and 100,000 common shares to Euro-Asia Investment & Finance Corp Ltd.

and Thalia Media Ltd.

for consulting and advisory services.

On January 3, 2023, the Company issued 223,411

common shares to a consultant for providing consulting services on listing to NASDAQ in 2021.

On February 23, 2023, the Company entered into a securities purchase

agreement with Lind Global Fund II, LP (“Lind”), pursuant to which the Company issued Lind a secured, convertible note in

the principal amount of $3,704,167, for a purchase price of $3,175,000, that is convertible into shares of the Company’s common

stock at an initial conversion price of $1.05 per share, subject to adjustment.

The Company also issued Lind a common stock purchase warrant

to purchase up to 5,291,667 shares of the Company’s common stock at an initial exercise price of $1.05 per share, subject to adjustment.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity